These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8071038)

  • 1. Use of nonionic contrast media. Trends and experience with iopromide.
    Schild HH
    Invest Radiol; 1994 May; 29 Suppl 1():S112-7. PubMed ID: 8071038
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
    Druy EM; Bettmann MA; Jeans W
    Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
    Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
    Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New clinical trial experience with iopromide.
    Goldstein HA; Jacob G; Wiggins JR
    Invest Radiol; 1994 Jun; 29 Suppl 2():S208-10. PubMed ID: 7928233
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of iopromide with iohexol and iopamidol in coronary arteriography and left ventriculography.
    Bergelson B; Bettmann MA; Wexler L; Wilson R; Dyet J
    Invest Radiol; 1994 May; 29 Suppl 1():S107-11; discussion S118-9. PubMed ID: 8071037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
    Faykus MH; Cope C; Athanasoulis C; Druy EM; Hedgcock M; Miller FJ; Bron K
    Invest Radiol; 1994 May; 29 Suppl 1():S98-101; discussion S106. PubMed ID: 8071053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of iopromide in cerebral arteriography.
    Haughton VM; Papke RA; Hyland D; Drayer BP; Osborn AG; Maravilla K; Hilal SK
    Invest Radiol; 1994 May; 29 Suppl 1():S94-7. PubMed ID: 8071052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent toxic epidermal necrolysis secondary to iopromide contrast.
    Brown M; Yowler C; Brandt C
    J Burn Care Res; 2013; 34(1):e53-6. PubMed ID: 22929525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of electrocardiogram showing ST depression after nonionic contrast media (iopromide) administration].
    Tsuruta S; Matayoshi H; Nagamizo D; Morimoto Y; Sakabe T
    Masui; 2008 Feb; 57(2):219-22. PubMed ID: 18277577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience in using the new nonionic x-ray contrast medium Ultravist in neuroroentgenology].
    Kornienko VN; Arutiunov NV; Grindel' OM; Drozhzhin VA
    Zh Vopr Neirokhir Im N N Burdenko; 1993; (3):36-7. PubMed ID: 8256547
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse reactions to iopromide].
    Cuñat A; Chuliá R
    Med Clin (Barc); 1998 Oct; 111(11):437. PubMed ID: 9834920
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatotoxicity caused by iopromide].
    Bolado Concejo F; Capdevila Bastons F; Zozaya Urmeneta JM; González de la Higuera B; García Sanchotena JL
    Rev Esp Enferm Dig; 2008 Jun; 100(6):377-8. PubMed ID: 18752373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early hemodynamic cardiovascular reactions to nonionic low-osmolar contrast media in coronary angiography].
    Wink K
    Rontgenblatter; 1988 Sep; 41(9):384-8. PubMed ID: 3175478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodide mumps after intravascular administration of a nonionic contrast medium. Case report and review of the literature.
    Christensen J
    Acta Radiol; 1995 Jan; 36(1):82-4. PubMed ID: 7833175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are nonionic contrast media identical in their tolerability? Results of a double-blind randomized multicenter study with iomeprol and iopromide].
    Schmiedel E
    Aktuelle Radiol; 1997 Jul; 7(4):183-8. PubMed ID: 9340014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-center clinical study on the effect of chronic renal impairment on safety of iopromide 300 mg iodine/ml.
    Harz C; Fallenberg EM; Schäfer R; Magnusson A; Clauss W; Heindel W; Tombach B
    Acad Radiol; 2002 Aug; 9 Suppl 2():S535-9. PubMed ID: 12188331
    [No Abstract]   [Full Text] [Related]  

  • 17. Contrast-induced monoplegia following coronary angioplasty with iopromide.
    Aykan A; Zehir R; Karabay CY; Kocabay G
    Kardiol Pol; 2012; 70(5):499-500. PubMed ID: 22623245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.
    Hoogewoud HM; Woessmer B
    Acta Radiol Suppl; 1996; 400():62-4. PubMed ID: 8619354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-induced encephalopathy following coronary angioplasty with iopromide.
    Jiang X; Li J; Chen X
    Neurosciences (Riyadh); 2012 Oct; 17(4):378-9. PubMed ID: 23022906
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of thrombin by iopromide in vitro.
    Graf LL; Young DA; Kressin DC; Marlar RA; Jacob GB; Hinderling PH
    Ther Drug Monit; 2001 Apr; 23(2):93-9. PubMed ID: 11294523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.